Kenvue (NYSE:KVUE – Get Free Report) and Honest (NASDAQ:HNST – Get Free Report) are both consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings and risk.
Valuation & Earnings
This table compares Kenvue and Honest”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Kenvue | $15.12 billion | 2.42 | $1.47 billion | $0.87 | 21.93 |
| Honest | $371.32 million | 1.50 | -$15.69 million | ($0.11) | -45.91 |
Profitability
This table compares Kenvue and Honest’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Kenvue | 10.76% | 21.22% | 8.37% |
| Honest | -3.56% | 4.31% | 3.33% |
Risk & Volatility
Kenvue has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500. Comparatively, Honest has a beta of 2.12, meaning that its stock price is 112% more volatile than the S&P 500.
Analyst Ratings
This is a summary of recent ratings and recommmendations for Kenvue and Honest, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Kenvue | 0 | 12 | 3 | 0 | 2.20 |
| Honest | 2 | 4 | 2 | 1 | 2.22 |
Kenvue currently has a consensus target price of $19.27, suggesting a potential upside of 1.01%. Honest has a consensus target price of $4.84, suggesting a potential downside of 4.16%. Given Kenvue’s higher probable upside, research analysts plainly believe Kenvue is more favorable than Honest.
Institutional and Insider Ownership
97.6% of Kenvue shares are owned by institutional investors. Comparatively, 45.5% of Honest shares are owned by institutional investors. 1.6% of Kenvue shares are owned by insiders. Comparatively, 9.4% of Honest shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
Kenvue beats Honest on 11 of the 15 factors compared between the two stocks.
About Kenvue
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.
About Honest
The Honest Company, Inc. manufactures and sells diapers and wipes, skin and personal care, and household and wellness products. The company also offers baby clothing and nursery bedding products. It sells its products through digital and retail sales channels, such as its website and third-party ecommerce sites, as well as brick and mortar retailers. The company was incorporated in 2012 and is headquartered in Los Angeles, California.
Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.
